World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
96
Citations
27998
World Ranking
523
National Ranking
242

Overview

Shawn A. Messer is affiliated with Oregon Health & Science University in the United States. Their research primarily focuses on medicine, with a particular emphasis on infectious diseases, epidemiology, and cell biology.

The scientist's work often addresses topics within antifungal resistance and susceptibility, fungal infections and studies, and plant pathogens and fungal diseases. Additional areas of interest include infectious diseases and mycology, insect and parasite interactions, microbial natural products and biosynthesis, and nematode management and characterization studies.

Recent publications by Shawn A. Messer include:

  • "Activity of a Long-Acting Echinocandin, Rezafungin, and Comparator Antifungal Agents Tested against Contemporary Invasive Fungal Isolates (SENTRY Program, 2016 to 2018)" (2020), published in Antimicrobial Agents and Chemotherapy
  • "Evaluation of Synergistic Activity of Isavuconazole or Voriconazole plus Anidulafungin and the Occurrence and Genetic Characterization of Candida auris Detected in a Surveillance Program" (2021), published in Antimicrobial Agents and Chemotherapy
  • "Antifungal susceptibilities of opportunistic filamentous fungal pathogens from the Asia and Western Pacific Region: data from the SENTRY Antifungal Surveillance Program (2011-2019)" (2021), published in The Journal of Antibiotics
  • "In vitro activity of isavuconazole versus opportunistic filamentous fungal pathogens from the SENTRY Antifungal Surveillance Program, 2017-2018" (2020), published in Diagnostic Microbiology and Infectious Disease
  • "In vitro activity of posaconazole and comparators versus opportunistic filamentous fungal pathogens globally collected during 8 years" (2021), published in Diagnostic Microbiology and Infectious Disease

Frequent coauthors collaborating with Shawn A. Messer include:

  • Michael A. Pfaller
  • Mariana Castanheira
  • Paul R. Rhomberg
  • Cecília G Carvalhaes
  • Lalitagauri M. Deshpande

Key publication venues where their work has appeared multiple times are:

  • Antimicrobial Agents and Chemotherapy
  • The Journal of Antibiotics
  • Diagnostic Microbiology and Infectious Disease
  • Open Forum Infectious Diseases
  • Future Microbiology

Best Publications

  • Attributable Mortality of Nosocomial Candidemia, Revisited

    Olafur Gudlaugsson;Olafur Gudlaugsson;Shane Gillespie;Kathleen Lee;Jeff Vande Berg

  • Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations

    Barbara D. Alexander;Melissa D. Johnson;Christopher D. Pfeiffer;Cristina Jiménez-Ortigosa

  • International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program.

    M. A. Pfaller;D. J. Diekema;R. N. Jones;H. S. Sader

  • Antifungal Susceptibilities of Candida Species Causing Vulvovaginitis and Epidemiology of Recurrent Cases

    Sandra S. Richter;Rudolph P. Galask;Shawn A. Messer;Richard J. Hollis

  • National Surveillance of Nosocomial Blood Stream Infection Due to Species of Candida Other than Candida albicans: Frequency of Occurrence and Antifungal Susceptibility in the SCOPE Program

    Michael A Pfaller;Ronald N Jones;Shawn A Messer;Michael B Edmond

  • Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program, 2000.

    M. A. Pfaller;S. A. Messer;R. J. Hollis;R. N. Jones

  • Epidemiology of Candidemia: 3-Year Results from the Emerging Infections and the Epidemiology of Iowa Organisms Study

    D. J. Diekema;S. A. Messer;A. B. Brueggemann;S. L. Coffman

  • In Vitro Susceptibility of Invasive Isolates of Candida spp. to Anidulafungin, Caspofungin, and Micafungin: Six Years of Global Surveillance

    M. A. Pfaller;L. Boyken;R. J. Hollis;J. Kroeger

  • Bloodstream Infections Due to Candida Species: SENTRY Antimicrobial Surveillance Program in North America and Latin America, 1997-1998

    Pfaller;R N Jones;G V Doern;H S Sader

  • Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi

    D. J. Diekema;S. A. Messer;R. J. Hollis;R. N. Jones

  • Frequency of Decreased Susceptibility and Resistance to Echinocandins among Fluconazole-Resistant Bloodstream Isolates of Candida glabrata

    M. A. Pfaller;M. Castanheira;S. R. Lockhart;A. M. Ahlquist

  • National Surveillance of Nosocomial Blood Stream Infection Due to Candida albicans: Frequency of Occurrence and Antifungal Susceptibility in the SCOPE Program

    M.A Pfaller;R.N Jones;S.A Messer;M.B Edmond

  • Trends in Antifungal Susceptibility of Candida spp. Isolated from Pediatric and Adult Patients with Bloodstream Infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000

    M. A. Pfaller;D. J. Diekema;R. N. Jones;S. A. Messer

  • International Surveillance of Bloodstream Infections Due to Candida Species: Frequency of Occurrence and Antifungal Susceptibilities of Isolates Collected in 1997 in the United States, Canada, and South America for the SENTRY Program

    M. A. Pfaller;R. N. Jones;G. V. Doern;H. S. Sader

  • International surveillance of blood stream infections due to Candida species in the European SENTRY program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents

    M.A Pfaller;R.N Jones;G.V Doern;A.C Fluit

  • Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009)

    Michael A. Pfaller;Shawn A. Messer;Gary J. Moet;Ronald N. Jones

  • In vitro activities of voriconazole, posaconazole, and fluconazole against 4,169 clinical isolates of Candida spp. and Cryptococcus neoformans collected during 2001 and 2002 in the ARTEMIS global antifungal surveillance program

    M.A Pfaller;S.A Messer;L Boyken;R.J Hollis

  • In Vitro Activities of Ravuconazole and Voriconazole Compared with Those of Four Approved Systemic Antifungal Agents against 6,970 Clinical Isolates of Candida spp.

    M. A. Pfaller;S. A. Messer;R. J. Hollis;R. N. Jones

  • Echinocandin and Triazole Antifungal Susceptibility Profiles for Clinical Opportunistic Yeast and Mold Isolates Collected from 2010 to 2011: Application of New CLSI Clinical Breakpoints and Epidemiological Cutoff Values for Characterization of Geographic and Temporal Trends of Antifungal Resistance

    Michael A. Pfaller;Shawn A. Messer;Leah N. Woosley;Ronald N. Jones

  • Candida Bloodstream Infections: Comparison of Species Distributions and Antifungal Resistance Patterns in Community-Onset and Nosocomial Isolates in the SENTRY Antimicrobial Surveillance Program, 2008-2009

    Michael A. Pfaller;Gary J. Moet;Shawn A. Messer;Ronald N. Jones

  • Bloodstream Infections Due to Candida Species: SENTRY Antimicrobial Surveillance Program in North America

    M. A. Pfaller;R. N. Jones;G. V. Doern

Frequent Co-Authors

Michael A. Pfaller
Michael A. Pfaller JMI Laboratories
Daniel J. Diekema
Daniel J. Diekema University of Iowa Hospitals and Clinics
Richard J. Hollis
Richard J. Hollis University of Iowa
Mariana Castanheira
Mariana Castanheira JMI Laboratories
Ronald N. Jones
Ronald N. Jones JMI Laboratories
Paul R. Rhomberg
Paul R. Rhomberg University of Iowa
Mahmoud A. Ghannoum
Mahmoud A. Ghannoum Case Western Reserve University
Shawn R. Lockhart
Shawn R. Lockhart Centers for Disease Control and Prevention
Francesc Marco
Francesc Marco University of Barcelona
Gary V. Doern
Gary V. Doern University of Iowa

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to various related fields and career pathways, many of which can be pursued through online education. For example, public health professionals often complement their microbiology background by exploring which online mph programs are easiest to get into. These programs can offer flexible options for advancing your knowledge in disease prevention and health management.

For those interested in healthcare and child development, certifications like the ccls certification can enhance career prospects in specialized roles. This credential supports work with children coping with medical challenges, which often aligns with microbiology-related medical fields.

Additionally, online options provide opportunities for individuals with diverse backgrounds. Understanding what is the best degree for a convicted felon is important for those seeking second chances in education and career paths related to the health sciences.

Lastly, careers like becoming a Functional Medicine Nurse Practitioner are gaining popularity. Exploring the functional medicine nurse practitioner salary can help gauge the financial benefits of this specialized healthcare role for microbiology graduates.

Best Scientists Citing Shawn A. Messer

Trending Scientists

Recently Published Articles